Tipiracil
ATC — · 8 markets · 22 records
ES 4 records · 2 strengths
AU 3 records · 3 strengths
- 8.19 mgtabletLonsurf 20/8.19
- 6.14 mgtabletLonsurf 15/6.14
Records without a stated strength · 1 LONSURF
US 2 records · 2 strengths
GB 2 records · 2 strengths
CA 2 records · 2 strengths
TW 2 records · 1 strengths
Records without a stated strength · 1 LONSURF、朗斯弗膜衣錠15毫克、朗斯弗膜衣錠20毫克
HK 2 records · 1 strengths
Records without a stated strength · 1 LONSURF
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 LONSURF
| Strength / form / release | US | GB | CA | AU | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|
| 8.19 mg tablet | LONSURF | LONSURF | LONSURF | Lonsurf 20/8.19 | LONSURF | |||
| 6.14 mg tablet | LONSURF | LONSURF | LONSURF | Lonsurf 15/6.14 | LONSURF | |||
tablet | LONSURF 朗斯弗膜衣錠15毫克 朗斯弗膜衣錠20毫克 | |||||||
unknown | LONSURF | LONSURF | LONSURF |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.